Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | PTPRA | P18433 | 1/20 | 0.60 |
| ▸ | PTPRB | P23467 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.56 |
| ▸ | MPL | P40238 | 5/20 | 0.55 |
| ▸ | CTRC | Q99895 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31525848 | 1.00 | CYP1A2 (0.67) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL11763437 | 1.00 | CYP1A2 (0.67) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL11227186 | 0.87 | CYP1A2 (0.80) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL29767885 | 0.87 | CYP1A2 (0.80) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL11227192 | 0.87 | CYP1A2 (0.80) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL29436781 | 0.86 | KMT2A (0.55) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL30960384 | 0.85 | CTRB1 (0.71) | CYP1A2MAPK1CYP2C9KMT2AMEN1 | |
| SCHEMBL11693259 | 0.85 | CYP1A2 (0.60) | CYP1A2MAPK1CYP2C9DNASE1L3KMT2A | |
| SCHEMBL6763835 | 0.84 | CTRB1 (0.73) | CYP1A2MAPK1CYP2C9KMT2AMEN1 | |
| SCHEMBL5701120 | 0.84 | CTRB1 (0.73) | CYP1A2MAPK1CYP2C9KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7264932-B2 | Nuclease inhibitor cocktail | APPLERA CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070032418-A1 | Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same | AMBION, INC (US) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032418-A1 | Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same | RNASE1, RNASEH1, RNASEL | CYP1A2 4375/4885MAPK1 3346/4885CYP2C9 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.